Matrix Asset Management is a wealth management company based in Vancouver, British Columbia, offering services to both individual and institutional investors throughout Canada. Established in 1998, the company operates through three divisions: GrowthWorks Capital Ltd, a venture capital firm; Matrix Funds Management Inc; and SEAMARK Asset Management Ltd. Each division specializes in different aspects of asset management, providing a comprehensive range of investment solutions tailored to meet the diverse needs of its clients.
EmerGeo Solutions Worldwide Inc. specializes in the development and support of emergency management software and services aimed at enhancing crisis response and safety for governments and industries globally. The company offers integrated products such as Fusionpoint, a web-based crisis information management system, and a mapping software suite designed to facilitate multi-agency interoperability and real-time situational awareness. These tools enable clients to effectively prepare for, respond to, and recover from various incidents, including natural disasters and acts of terrorism. EmerGeo Solutions, headquartered in Vancouver, Canada, has successfully deployed its software to a diverse range of clients across North America, Australia, and the Middle East. Founded in 1997, the company was previously known as Kavalmedia Services Ltd. before rebranding in 2008.
Valocor Therapeutics
Venture Round in 2010
Valocor Therapeutics, Inc. is a clinical-stage biotechnology company based in Vancouver, Canada, focused on developing innovative therapies for dermatological conditions that lack effective treatments. The company's product pipeline includes Lemuteporfin, a targeted topical photodynamic therapy for severe acne, and VAL-001, a topical sebum inhibitor aimed at reducing acne and sebaceous gland hyperactivity. Additionally, Valocor is developing VAL-002, a small-molecule kinase inhibitor designed for the topical treatment of chronic inflammatory skin diseases, and VAL-003, a kinase inhibitor with dual functions in melanin stimulation and immune modulation. Founded in 2008, Valocor Therapeutics is dedicated to addressing significant unmet medical needs in dermatology through its advanced therapeutic solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.